Sinovac Biotech SVA Balance Sheet (2010-2025)

NASDAQ SVA
$6.47 +0.00 (+0.00%)
At close: Oct 14, 2026 · 4:00 PM EDT
Reported Financials

Sinovac Biotech Quarterly Balance Sheet

Periods 16 quarters
Latest Dec 2025

Sinovac Biotech reported total assets of $8.54B and total liabilities of $2.15B for the quarter ended Dec 2025, down 49.0% year over year. This balance sheet covers 16 quarters of results from Dec 2010 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024 Dec2025
Assets
Current Assets
Cash & EquivalentsCash & Equiv. 101.59M104.29M91.22M106.52M89.79M63.83M62.43M114.42M158.17M152.72M1,041.01M11,608.86M3,878.68M1,123.96M335.27M488.25M
Short-term InvestmentsInvestments (Current) 1.51M18.91M50.27M135.25M1,806.45M6,653.67M9,894.58M9,613.33M5,483.07M
Cash & Current Investments 103.10M104.29M91.22M106.52M89.79M63.83M62.43M114.42M177.08M202.99M1,176.26M13,415.30M10,532.35M11,018.53M9,948.60M5,971.32M
Receivables - NetNet Receivables 22.37M17.83M23.44M31.93M40.72M39.02M49.83M66.21M74.46M113.74M253.49M942.74M486.59M424.95M300.89M286.34M
Receivables - OtherOther Receivables 3.40M30.98M31.02M22.65M19.35M20.40M
Receivables 25.77M17.83M23.44M31.93M40.72M39.02M49.83M66.21M74.46M113.74M253.49M973.71M517.61M447.60M320.24M306.75M
Raw Materials 3.23M1.30M3.83M2.69M3.30M4.84M5.69M29.01M111.71M88.00M61.65M31.59M25.84M
Work In Process 0.45M0.97M0.45M4.06M3.28M3.93M8.57M52.52M141.33M41.12M39.37M37.05M38.88M
Finished Goods 4.44M8.26M10.05M12.09M13.05M16.33M13.59M24.29M138.03M46.17M34.59M28.28M29.59M
Inventory 14.54M8.11M10.53M14.33M18.71M18.66M14.10M19.62M25.09M27.85M105.81M391.07M175.29M135.61M96.92M94.31M
Current Deferred Tax AssetsCurrent Deferred Tax 2.68M2.60M2.27M2.60M3.49M
Prepaid Assets 0.89M1.80M1.07M1.15M1.43M0.96M1.37M2.10M4.54M1.87M15.54M150.23M18.37M13.05M15.72M17.60M
Current Assets 146.98M132.04M126.28M157.25M154.80M128.49M130.75M203.89M284.18M349.61M1,560.29M14,937.76M11,304.69M11,597.30M10,644.52M7,064.50M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net) 64.04M75.63M69.17M67.96M66.23M63.91M66.88M76.43M70.92M74.31M200.37M855.04M989.73M951.98M880.97M706.06M
Long-Term Investments 40.04M38.62M72.05M99.49M149.09M609.06M655.84M1,426.08M879.84M491.35M512.32M
Goodwill 27.51M12.60M
Intangibles 1.34M1.15M1.47M1.48M9.70M8.52M122.58M77.68M
Goodwill & Intangibles 1.34M1.15M1.47M1.48M9.70M8.52M150.09M90.28M
Long-Term Deferred Tax 0.51M0.42M0.45M0.12M0.52M0.59M3.94M9.32M5.80M11.37M26.89M27.56M30.13M38.23M37.37M41.52M
Other Non-Current Assets 1.09M1.24M0.77M0.86M3.72M0.35M0.99M0.03M0.02M0.02M0.03M1.61M19.21M20.91M20.49M18.28M
Non-Current Assets 67.38M83.87M82.48M83.44M83.73M74.43M80.61M95.33M85.61M102.69M341.03M1,820.94M2,725.86M2,014.72M1,692.77M1,477.23M
Assets 214.36M215.91M208.76M240.69M238.53M202.93M211.36M299.22M369.78M452.30M1,901.33M16,758.69M14,030.54M13,612.02M12,337.28M8,541.73M
Liabilities
Current Liabilities
Accounts Payables 22.09M29.52M24.78M28.04M-3.49M22.66M24.96M59.42M49.99M58.89M211.43M1,029.69M924.65M989.25M803.00M604.68M
Notes Payables 3.32M5.93M32.94M3.10M0.29M76.09M211.92M229.37M
Dividends payables 0.80M5.13M11.14M118.89M212.96M657.86M
Payables 22.09M30.32M24.78M28.04M-3.49M22.66M24.96M59.42M53.31M69.95M255.51M1,032.79M1,043.84M1,065.33M1,227.88M1,491.91M
Accumulated Expenses 4.12M7.51M8.67M8.33M9.65M8.60M32.62M26.81M31.15M113.69M496.96M240.09M185.37M156.60M152.71M
Other Accumulated Expenses 0.91M0.62M0.58M0.21M0.62M1.36M0.52M4.68M18.07M3.00M1.62M0.90M
Short term Debt 10.44M4.71M3.33M16.22M47.38M21.78M31.28M18.15M3.32M
Current Taxes 0.96M3.35M0.24M0.25M1.10M1.64M3.18M8.86M1.90M35.26M1,392.50M161.55M192.66M207.72M30.69M
Current Deferred Revenue 0.72M1.38M0.88M5.00M8.14M2.77M4.07M2.91M5.46M363.79M79.72M25.54M27.05M12.21M11.27M
Curent Deferred Tax LiabilityCurent Deferred Tax 1.01M
Total Current Liabilities 45.76M39.53M30.16M49.16M79.83M58.14M66.26M92.54M58.21M87.20M679.61M2,518.57M1,256.40M1,292.71M1,451.90M1,540.37M
Non-Current Liabilities
Non-Current Debt 10.06M17.32M31.18M32.15M1.80M0.76M9.45M14.85M3.89M2.16M12.67M11.51M177.82M163.84M265.48M
Non-Current Deffered Revenue 3.48M10.37M10.69M11.01M7.49M4.73M2.95M4.47M5.96M3.99M4.23M15.84M4.48M5.87M4.84M5.89M
Minority Interest 21.32M15.38M11.71M14.96M15.16M14.85M13.90M25.99M38.50M58.18M373.65M4,558.16M3,752.59M3,326.73M2,031.17M1,957.31M
Liabilities from Discontinued OperationsLiabilities from Discont. Ops 0.73M0.24M
Non-Current Deferred Tax LiabilityNon-Current Deferred Tax 2.72M540.73M462.10M453.92M410.05M325.07M
Operating Leases 5.76M85.49M112.47M52.52M38.99M13.20M8.64M
Other Non-Current Liabilities 3.23M0.45M2.80M2.94M10.21M9.71M3.16M7.00M5.03M0.04M0.04M0.02M0.02M
Total Non-Current Liabilities 20.84M31.08M49.17M47.90M16.97M8.28M15.43M29.54M19.65M12.91M101.59M686.96M530.85M676.83M591.95M605.11M
Total Liabilities 66.60M70.61M79.33M97.75M98.39M66.42M81.69M122.08M77.85M100.10M770.06M3,205.52M1,787.25M1,969.55M2,043.85M2,145.47M
Shareholder's Equity
Total Debt 20.49M22.03M34.51M48.36M49.18M22.53M40.73M33.00M7.21M5.93M35.10M15.77M11.81M253.91M375.76M494.86M
Common Equity 147.76M145.30M129.44M142.94M140.15M136.51M129.67M177.14M291.93M352.20M1,131.27M13,553.17M12,243.30M11,642.48M10,293.43M6,396.25M
Liabilities and Shareholders Equity 214.36M215.91M208.76M240.69M238.53M202.93M211.36M299.22M369.78M452.30M1,901.33M16,758.69M14,030.54M13,612.02M12,337.28M8,541.73M
Retained Earnings 3.88M2.70M-12.16M-4.71M-6.38M-9.98M-11.91M9.13M23.82M56.73M144.24M6,813.65M6,804.40M6,789.34M6,838.36M2,815.94M
Preferred Shares 0.02M0.02M

Sinovac Biotech Balance Sheet API

Pull Sinovac Biotech's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SVA&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY